A Double-blind Study to Determine if Intraduodenal Indomethacin Can Decrease the Incidence of Post-ERCP Pancreatitis

NCT00727740 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

117

Enrollment

OTHER

Sponsor class

Conditions

Pancreatitis

Interventions

DRUG: Indomethacin
DRUG: Placebo suspension

Sponsor

Yale University